JPRN-UMIN000041785已完成未知
Treatment of laryngeal cancer in Japan - Treatment of laryngeal cancer in Japan
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 363
研究概览
简要总结
arynx-preserving treatment was used in most T1 and T2 cases (96.9%), and 40% of the patients with T3 cancer underwent total laryngectomy (adjusted odds ratio 26.7 [95% CI, 9.29-91.6]).
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 200years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •T4, N3, or M1 cases, as well as patients with unclear T stage, were excluded. Patients who had surgeries with Japanese procedure code C112 (tracheostomy), K394-2 (laryngectomy), K395 (pharyngolaryngectomy), K403-2-4 (laryngotracheal separation), and K403-2-3 (total laryngectomy for aspiration) before the index date, were also excluded.
研究者
相似试验
已完成
不适用
Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.Larynx CancerNCT03292341Maastricht Radiation Oncology9
进行中（未招募）
3 期
Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RTHead and Neck Squamous Cell CarcinomaNCT03340896Groupe Oncologie Radiotherapie Tete et Cou256
进行中（未招募）
1 期
Olaparib and Radiotherapy in Head and Neck CancerLaryngeal Cancer Stage IIILaryngeal Cancer Stage IIHead and Neck NeoplasmsCarcinoma, Squamous CellNCT02229656The Netherlands Cancer Institute12
尚未招募
1 期
Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer PatientsHead and Neck NeoplasmsOral Mucositis (Ulcerative) Due to RadiationChinese Medicine Oral RinseNCT05664906Chinese University of Hong Kong40
招募中
3 期
Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 TrialHypopharyngeal CancerNCT04502641Sun Yat-sen University160